Optimum Clinical Research Group

Albuquerque, New Mexico 87109

1 studies enrolling now · 2 studies all time

What they study most

Epithelial Ovarian Cancer, Fallopian Tube Cancer, Fallopian Tube Neoplasms, Neoplasm Metastasis, Ovarian Cancer, Ovarian Neoplasms, Peritoneal Neoplasms, Platinum-resistant Ovarian Cancer, Primary Peritoneal Cancer

Studies at this site

• A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer — Recruiting now
• REFRaME-O1: A Study to Investigate the Efficacy and Safety of Luveltamab Tazevibulin Versus Investigator's Choice (IC) Chemotherapy in Women With Ovarian Cancer (Including Fallopian Tube or Primary Peritoneal Cancers) Expressing FOLR1 — Stopped early